Patent Assignment
Reel/Frame 062799/0268
Change of Name
Recorded: 2023-02-18
Pages: 5
Assignor
CUREVAC AG
Executed: 2022-09-26
Assignee
CUREVAC SE
FRIEDRICH-MIESCHER-STRASSE 15, TÜBINGEN, 72076, GERMANY
Covered Properties
(33)
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
Nucleic Acid Comprising or Coding for a Histone Stem-Loop and a Poly(a) Sequence or a Polyadenylation Signal for Increasing the Expression of an Encoded Therapeutic Protein
Application:
17/020,517 →
Publication:
US 2021/0060181
Artificial Nucleic Acid Molecules Comprising a 5'TOP Utr
Artificial Nucleic Acid Molecules for Improved Protein or Peptide Expression
Artificial Nucleic Acid Molecules for Improved Protein or Peptide Expression
Artificial Nucleic Acid Molecules for Improved Protein or Peptide Expression
Method for Increasing Expression of Rna-Encoded Proteins
Method for Increasing Expression of Rna-Encoded Proteins
Artificial Nucleic Acid Molecules
Respiratory Syncytial Virus (Rsv) Vaccine
Respiratory Syncytial Virus (Rsv) Vaccine
Respiratory Syncytial Virus (Rsv) Vaccine
Respiratory Syncytial Virus (Rsv) Vaccine
Combination Vaccine
Combination Vaccine
Combination Vaccine
Modified Rna with Decreased Immunostimulatory Properties
Modified Rna with Decreased Immunostimulatory Properties
Artificial Nucleic Acid Molecules
Artificial Nucleic Acid Molecules
Artificial Nucleic Acid Molecules
Application:
17/576,583 →
Publication:
US 2022/0136001
Polymeric Carrier Cargo Complex for Use as an Immunostimulating Agent or as an Adjuvant
Polymeric Carrier Cargo Complex for Use as an Immunostimulating Agent or as an Adjuvant
Polymeric Carrier Cargo Complex for Use as an Immunostimulating Agent or as an Adjuvant
Application:
17/393,362 →
Publication:
US 2021/0361764
Combination of Vaccination and OX40 Agonists
Combination of Vaccination and OX40 Agonists
Combination of Vaccination and OX40 Agonists
Artificial Nucleic Acid Molecules
Application:
15/540,610 →
Publication:
US 2018/0148727
Artificial Nucleic Acid Molecules
Application:
16/523,214 →
Publication:
US 2019/0345504
Ebolavirus and Marburgvirus Vaccines
Application:
15/536,595 →
Publication:
US 2017/0326225
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 1, 2014
From: THESS, ANDREAS
To: CUREVAC GMBH
Reel/Frame 034288/0643 →
Assignment of Assignor's Interest
Dec 17, 2014
From: THESS, ANDREAS; SCHLAKE, THOMAS; PROBST, JOCHEN
To: CUREVAC GMBH
Reel/Frame 034534/0395 →
Assignment of Assignor's Interest
May 23, 2015
From: THESS, ANDREAS
To: CUREVAC GMBH
Reel/Frame 035703/0289 →
Change of Name
Nov 16, 2015
From: CUREVAC GMBH
To: CUREVAC AG
Reel/Frame 037115/0430 →
Assignment of Assignor's Interest
Apr 16, 2016
From: BAUMHOF, PATRICK
To: CUREVAC AG
Reel/Frame 038299/0902 →
Assignment of Assignor's Interest
Apr 27, 2016
From: KRAMPS, THOMAS; SCHNEE, MARGIT; VOSS, DANIEL; PETSCH, BENJAMIN
To: CUREVAC AG
Reel/Frame 038391/0207 →
Assignment of Assignor's Interest
Jun 21, 2016
From: KALLEN, KARL-JOSEF; KRAMPS, THOMAS; SCHNEE, MARGIT; VOSS, DANIEL
To: CUREVAC AG
Reel/Frame 038977/0810 →
Assignment of Assignor's Interest
Jul 31, 2016
From: GRUND, STEFANIE; SCHLAKE, THOMAS
To: CUREVAC AG
Reel/Frame 039298/0582 →
Confirmatory License
Jul 26, 2023
From: CUREVAC, GMBH
To: DEFENSE ADVANCED RESEARCH PROJECTS AGENCY
Reel/Frame 064388/0272 →